VIE/FRE2 (VIE/FRE2)

Vienna Stock Exchange: VIE/FRE2 · EUR

€46.7

+0.47 (+1.0%)· Recorded snapshot

Market cap	26.1B
Revenue (ttm)	23.3B
Net income (ttm)	1.5B
EPS (ttm)	€2.70
P/E (trailing)	17.3x
P/E (forward)	12.3x
Dividend	€1.05 (2.25%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 23.3B
Net income (ttm): 1.5B
EPS (ttm): €2.70
P/E (trailing): 17.3x
P/E (forward): 12.3x
Market cap: 26.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E12.3

P25 14.3P50 18.7P75 25.4

Trailing P/E17.3

P25 20.4P50 26.7P75 39.7

ROE8.3

P25 4.8P50 10.6P75 20.1

ROIC5.6

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/FRE2 indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

EUR

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-04
Employees	178,486
Employees change	2,279
Employees growth	1.29%
Enterprise value	EUR 36.9B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-09-03
Fiscal year end	December
Founded	1912
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	DE000FRE5EN2
Last refreshed	2026-10-29
Market cap	EUR 26.1B
Next earnings date	2026-11-04
Price	EUR 46.66
Price currency	EUR
Sector	Healthcare
SIC code	8060
Stock price date	2026-10-28
Symbol	vie/FRE2
Website	https://www.fresenius.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	18.86x
Average P/E ratio (3Y)	31.41x
Average P/E ratio (5Y)	21.18x
Earnings yield	5.79%
EV/Earnings	24.27x
EV/EBIT	15.14x
EV/EBITDA	10.92x
EV/FCF	21.38x
EV/Sales	1.59x
FCF / EV yield	4.68%
FCF yield	6.62%
Forward P/E	12.31x
Graham number	47.25494
Graham upside	1.28%
Lynch fair value	EUR 13.61
Lynch upside	-70.84%
P/B ratio	1.28x
P/E ratio	17.27x
P/FCF ratio	15.1x
P/OCF ratio	9.21x
P/S ratio	1.12x
Price / tangible book value	8.85x
Price/EBITDA ratio	8.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.8%
EBITDA margin	13.05%
Effective tax rate	25.64%
FCF margin	7.42%
Gross margin	25.35%
Operating margin	9.8%
Pretax margin	9.42%
Profit margin	6.54%
Profit per employee	EUR 8,527
Profitable quarters	8
Profitable years	2
Revenue per employee	EUR 130,436
ROA	3.43%
ROA (5Y)	2.54%
ROCE	6.96%
ROE	8.29%
ROE (5Y)	5.81%
ROIC	5.58%
ROIC (5Y)	3.88%
Tax / revenue	2.41%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	35.29%
EPS growth (Q)	17.24%
EPS growth (QoQ)	-11.95%
EPS growth 10Y	0.21%
EPS growth 3Y	12.67%
EPS growth 5Y	-2.83%
EPS growth quarters	5
EPS growth years	2
FCF growth	52.65%
FCF growth (Q)	-44.02%
FCF growth (QoQ)	-46.63%
FCF growth 3Y	-22.02%
FCF growth 5Y	-6.49%
Gross profit growth	4.04%
Gross profit growth (Q)	6.09%
Gross profit growth 3Y	4.26%
Gross profit growth 5Y	-10.36%
Net income growth	35.29%
Net income growth (Q)	15.76%
Net income growth (QoQ)	-12.18%
Net income growth 3Y	14.95%
Net income growth 5Y	-2.68%
Net income growth quarters	5
Net income growth years	2
OCF growth	28.13%
OCF growth (Q)	-17.7%
OCF growth (QoQ)	-11.57%
OCF growth 10Y	-1.83%
OCF growth 3Y	-13.92%
OCF growth 5Y	-9.6%
Operating income growth	6.12%
Operating income growth (Q)	12.46%
Operating income growth 3Y	15.55%
Operating income growth 5Y	-11.53%
Revenue growth	3.38%
Revenue growth (Q)	5.22%
Revenue growth (QoQ)	2.17%
Revenue growth 10Y	-1.97%
Revenue growth 3Y	2.59%
Revenue growth 5Y	-8.58%
Revenue growth quarters	9
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.1B
Depreciation and amortization	EUR 757M
EBIT	EUR 2.3B
EBITDA	EUR 3B
EPS	EUR 2.70
Financing cash flow	EUR -2.2B
Free cash flow	EUR 1.7B
Gross profit	EUR 5.9B
Income taxes	EUR 562M
Investing cash flow	EUR -637M
Net borrowing	EUR -1.6B
Net cash flow	EUR 53M
Net income	EUR 1.5B
Operating income	EUR 2.3B
Revenue	EUR 23.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.02
Book value per share	EUR 34.97
Debt / EBITDA	3.54
Debt / equity	0.56
Debt / FCF	6.61
Goodwill	EUR 14.7B
Interest coverage	5.42
Long-term assets	EUR 30.2B
Long-term liabilities	EUR 12.4B
Net cash (debt)	EUR -10.1B
Net cash / market cap	-38.85%
Net debt / EBITDA	3.34
Net debt / equity	0.5
Net debt / FCF	5.87
Piotroski F-Score	7
Property, plant and equipment	EUR 9.8B
Shareholders' equity	EUR 20.4B
Tangible book value	EUR 2.9B
Tangible book value per share	EUR 5.24
Total assets	EUR 41.8B
Total cash	EUR 1.3B
Total debt	EUR 11.4B
Total liabilities	EUR 21.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.56
Current assets	EUR 11.6B
Current liabilities	EUR 9.1B
Current ratio	1.28
Inventory turnover	6.48
Net working capital	EUR 3.1B
Quick ratio	0.65
Working capital	EUR 2.5B
Working capital turnover	9.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	5%
Dividend growth (3Y)	4.5%
Dividend growth (5Y)	-9.4%
Dividend growth years	1
Dividend payment date	2026-05-27
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	EUR 1.05
Dividend yield	2.25%
Ex-dividend date	2026-05-25
Last dividend	EUR 1.05
Payout ratio	32.72%
Shareholder yield	2.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 42.84
1D price change	1.02%
1M price change	1.35%
1M total return	1.35%
1W price change	2.41%
1W total return	2.41%
1Y price change	-5.35%
1Y return CAGR	-2.73%
1Y total return	-2.73%
20-day SMA	EUR 44.75
200-day SMA	EUR 44.36
3M price change	5.23%
3M total return	5.23%
3Y price change	90.14%
3Y return CAGR	26%
3Y total return	100.06%
50-day SMA	EUR 45.45
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 52.76
52-week high date	2026-02-19
52-week low	EUR 35.24
52-week low date	2026-06-02
5Y price change	14.69%
5Y return CAGR	5.11%
5Y total return	28.27%
6M price change	15.78%
6M total return	19%
All-time high	EUR 79.70
All-time high date	2017-06-19
All-time low	EUR 20.00
All-time low date	2022-10-13
Average true range (ATR)	EUR 0.82
Average volume	9
Change from 52-week high	-11.56%
Change from 52-week low	32.41%
Change from all-time high	-41.46%
Change from all-time low	133.3%
Change from open	1.06%
Day's gap	-0.04%
High price	EUR 46.66
Low price	EUR 45.95
Monthly RSI	58.13
Open price	EUR 46.17
Position in 52-week range	100%
Previous close	EUR 46.19
Price vs 150-day SMA	8.92%
Price vs 20-day SMA	4.27%
Price vs 200-day SMA	5.18%
Price vs 50-day SMA	2.66%
Relative volume	17
RSI	61.57
Sharpe ratio	-0.03
Sharpe ratio (3Y)	0.91
Sharpe ratio (5Y)	0.2
Sortino ratio	0.16
Sortino ratio (3Y)	1.61
Sortino ratio (5Y)	0.49
Weekly RSI	55.65
YTD price change	-4.29%
YTD total return	-1.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	410.6M
Shares change (QoQ)	-0.26%
Shares held by institutions	38.26%

Deeper analysis on VIE/FRE2

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/FRE2 report

Is a complete VIE/FRE2 research report available?

No complete published report is available for vie/FRE2 (VIE/FRE2) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/FRE2 (VIE/FRE2)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/FRE2

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/FRE2 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/FRE2

Frequently asked questions